Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

NCT06399640 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Relapsed Myelodysplastic Syndrome
Refractory Myelodysplastic Syndrome
Acute Myeloid Leukemia
Recurrent Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia

Interventions

DRUG: Eltanexor
DRUG: Venetoclax
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Biospecimen Collection

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]
[object Object]